Registered entities
Alladapt Immunotherapeutics, Inc.
Reg. No. 824879870Belgium
Investor mix
7 investors on record; lead investors include Gurnet Point Capital, Enavate Sciences.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 29% |
| Private equity | 2 | 29% |
| Bank & private debt | 1 | 14% |
| Other / undisclosed | 2 | 29% |